Bruker (BRKR) FCF Payout Ratio (QoQ) (2016 - 2026)
Bruker (BRKR) FCF Payout Ratio (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn |
| 10 | Bruker | 9.26 Bn | 9.26 Bn | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 346.73% |
| Dec 31, 2025 | 125.77% |
| Sep 30, 2025 | -175.05% |
| Jun 30, 2025 | -125.87% |
| Mar 31, 2025 | 298.25% |
| Dec 31, 2024 | -96.22% |
| Sep 30, 2024 | 499.91% |
| Jun 30, 2024 | -101.80% |
| Mar 31, 2024 | 43,400.00% |
| Dec 31, 2023 | -90.25% |
| Sep 30, 2023 | 1,605.81% |
| Jun 30, 2023 | -124.13% |
| Mar 31, 2023 | 119.04% |
| Dec 31, 2022 | -91.38% |
| Sep 30, 2022 | 620.93% |
| Jun 30, 2022 | -194.38% |
| Mar 31, 2022 | 134.27% |
| Dec 31, 2021 | -93.22% |
| Sep 30, 2021 | 109.36% |
| Jun 30, 2021 | -10,399.77% |